| Date |
Description |
Institution |
# Students |
| 9/2013 - Present |
Mind, Brain & Behavior |
The University of Texas Health Science Center |
200 students |
| Lecture and Case Presentation Child and Adolescent Psychopathology to MS II`s |
| 6/1995 - Present |
Child & Adolescent Psychiatry |
The University of Texas Health Science Center |
|
| Co-Course Director - Supervise and coordinate MS IV`s on Child Psychiatry Selective |
| 7/1989 - Present |
Neurobiology and Advanced Psychopharmacology |
|
3 students |
| Teach neurobiology relevant to psychiatric disorders to child and adolescent psychiatry residents |
| 7/1986 - Present |
Child & General Psychiatry Resident Supervision |
ClarityChild Guidance Center |
4 students |
| Supervise 1-2 General Psychiatry PG III residents and 1-2 Child and Adolescent Psychiatry resident one half day a week in a child psychiatry outpatient mental health setting. |
| 7/1986 - Present |
Psychiatry Clerkship |
The University of Texas Health Science Center |
200 students |
| Lecture to third year psychiatry clerks on psychiatric interview of the child and adolescent; supervise MSIII`s in child psychiatry outpatient clinic |
| 7/1986 - Present |
Child and Adolescent Psychiatric Disorders |
|
6 students |
| Discuss the diagnosis and treatment of ADHD, tic disorders, learning disabilities and brain injury related to psychiatric disorders to child & adolescent psychiatry residents |
Book Chapter |
| Pliszka SR. Attention Deficit Hyperactivity Disorder. In: Mina Dulcan, Editor. Dulcan's Textbook of Child and Adolescent Psychiaty. New York: American Psychiatric Publishing, Inc; 2015. |
| Pliszka SR. Comorbid Psychiatric Disorders. In: Russell Barkley, editor. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis. New York: Guilford Press; 2015. |
| Pliszka SR. Psychostimulants. In: Rosenberg DR, Gershon S. Pharmacotherapy of Child and Adolescent Disorders. West Sussex, UK: Wiley Blackwell; 2012. p. 65-104.
|
Book/Monograph |
| Pliszka SR. Neuroscience for the Mental Health Clinician, 2nd Edition 2015. |
Journal Article |
| Cha, J., Fekete, T., Siciliano, F., Biezonski, D., Greenhill, L., Pliszka, S. R.,Posner, J. Neural Correlates of Aggression in Medication-Naive Children with ADHD: Multivariate Analysis of Morphometry and Tractography Neuropsychopharmacology 2015 Jul;40(7):1717-1725.
|
| Olvera RL, Glahn DC, O`Donnell L, Bearden CE, Soares JC, Winkler AM, Pliszka SR. Cortical Volume Alterations in Conduct Disordered Adolescents with and without Bipolar Disorder J Clin Med 2014 Apr;3(2):416-431.
|
| Semrud-Clikeman, M, Pliszka SR, Bledsoe, J, Lancaster JL. Volumetric MRI differences in treatment naive and chronically treated adolescents with ADHD combined type Journal of Attention Disorders 2014 Jan;18(6):511-520.
|
| Blader JC, Pliszka SR, Kafantaris V, Foley CA, Crowell JA, Carlson GA, Sauder C, Margulies J, Sinha C, Sverd J, Matthews TL, Bailey BY, Daviss WB. Callous-unemotional traits, proactive aggression, and treatment outcomes of aggressive children with attention-deficit/hyperactivity disorder Journal of the American Academy of Child and Adolescent Psychiatry 2013 Dec;52(12):1281-1293.
|
| Daviss WB, O`Donnell L, Soileau, B, Heard, P, Carter, E, Pliszka SR, Gelfond JA, Hale DE, Cody JD. Mood disorders in individuals with distal 18q deletions Am J Med Genet B Neuropsychiatr Genet 2013 Jan;162(8):879-888.
|
| Bledsoe JC, Semrud-Clikeman M, Pliszka SR. Anterior cingulate cortex and symptom severity in attention-deficit/hyperactivity disorder Journal of Abnormal Psychology 2013 Jan;122(2):558-565.
|
| Pliszka SR. Tracking the development of bipolar disorder in childhood Am J Psychiatry 2012 Jun;169(6):557-559.
|
| Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics Journal of Managed Care Pharmacy 2012 Jan;18(9):676-689.
|
| Caetano SC, Olvera RL, Hatch JP, Sanches M, Chen HH, Nicoletti M, Stanley JA, Fonseca M, Hunter K, Lafer B, Pliszka SR, Soares JC. Lower N-acetyl-aspartate levels in prefrontal cortices in pediatric bipolar disorder: a ?H magnetic resonance spectroscopy study J Am Acad Child Adolesc Psychiatry 2011 Jan;50(1):85-94.
|
| Caetano SC, Olvera RL, Glahn DC, Fonseca M, Pliszka SR, Soares JC. Fronto-limbic brain abnormalities in juvenile onset bipolar disorder Biological Psychiatry 2005 Oct;58(7):525-531.
|
| Olvera RL, Glahn DC, Caetano SC, Pliszka SR, Soares JC. Neuroimaging studies in bipolar children and adolescents Int Rev Neurobiol 2004 Jan;62:121-146.
|
Not Specified |
| Blader JC, Pliszka SR, Kafantaris V. Prevalence and Treatment Outcomes of Persistent Negative Mood Among Children with Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior J Child Adolesc Psychopharmacol 2016 Feb;26(2):164-173.
|
| Bledsoe, J. C., Xiao, D., Chaovalitwongse, A., Mehta, S., Grabowski, T. J., Semrud-Clikeman, M. Diagnostic Classification of ADHD Versus Control: Support Vector Machine Classification Using Brief Neuropsychological Assessment Journal of Attention Disorders 2016 Jan;40(7).
|
| Sikirica, V., Pliszka, S. R., Betts, K. A., Hodgkins, P., Samuelson, T. M., Xie, J., Wu, E. Q. Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder American Journal of Managed Care 2014 Sep;20(9):711-721.
|
Federal |
| Funding Agency |
National Institute of Mental Health |
| Title |
Stepped Pharmacotherapy for Aggressive Youth with ADHD |
| Status |
Active |
| Period |
5/2008 - 4/2015 |
| Role |
Co-Investigator |
| Grant Detail |
In this 3-site trial (Overall PI: Blader), children with ADHD and aggression are first treated with stimulants and behavioral therapy. Non-responders to this initial treatment are randomized to receive risperidone, valproate or placebo for a 6-week trial. Our main hypothesis is that the two active drug conditions will be superior to placebo in reducing aggressive behaviors. |
| Funding Agency |
NIMH |
| Title |
Neuroimaging of Diet and Medication in the Treatment of ADHD |
| Status |
Active |
| Period |
1/2013 - 12/2014 |
| Role |
Principal Investigator |
| Grant Detail |
Study the effect of diet on brain function and as a treatment for ADHD |
Private |
| Funding Agency |
Meadows Foundation |
| Title |
Semp Russ Research Professorship in Child Psychiatry |
| Status |
Active |
| Period |
9/2000 - Present |
| Role |
Principal Investigator |
| Grant Detail |
Funds pilot research projects and supports ongoing child psychiatry research at UTHSCSA. |
| Funding Agency |
Ironshore Pharma |
| Title |
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Evening-dosed HLD200, a Novel Delayed and Extended Release Formulation (DELEXIS) of Methylphenidate Hydrochloride, on Post-w |
| Status |
Complete |
| Period |
1/2016 - 12/2016 |
| Role |
Principal Investigator |
| Grant Detail |
Trial of ADHD medication which can be dose in evening to be effective the next day |
| Funding Agency |
Hogg Foundation for Mental Health |
| Title |
The neural and genetic effects of anxious youth at high-risk for bipolar disorder |
| Status |
Active |
| Period |
4/2014 - 5/2015 |
| Role |
Co-Investigator |
| Grant Detail |
The goals of this study are to examine the association between early life stress and DNA changes in anxious children at high-risk for bipolar disorder (AHR-BD). We will also explore if these DNA changes are reflected in brain activation when these children experience an acute social rejection paradigm using functional magnetic resonance imaging (fMRI) |
| Funding Agency |
Purdue Pharma Canada |
| Title |
A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-ARM, MULTI-CENTER STUDY MEASURING THE EFFICACY AND SAFETY OF PRC-063 IN ADOLESCENT AND ADULT ADHD PATIENTS WITH AN OPEN LABEL FOLLOW ON. |
| Status |
Active |
| Period |
5/2014 - 5/2015 |
| Role |
Principal Investigator |
| Grant Detail |
Study of a new long acting methylphenidate in the treatment of ADHD |
